Werner Kroll - 27 May 2022 Form 4 Insider Report for QUIDEL CORP /DE/

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Jun 2022, 16:23:07 UTC
Prior SEC filing
14 Feb 2022
Next SEC filing
06 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip S. Askim, attorney-in-fact for Werner Kroll

Key filing fact

Werner Kroll filed Form 4 for QUIDEL CORP /DE/ on 01 Jun 2022.

Key facts

  • This page summarizes Werner Kroll's Form 4 filing for QUIDEL CORP /DE/.
  • 15 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 01 Jun 2022, 16:23.

Change

  • Previous filing in this sequence was filed on 14 Feb 2022.
  • Current net transaction value: -$224,486.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Award

Transaction value
$0
Shares
+4,376
Change %
+26%
Price
$0.000000
Shares after
20,932
Date
27 May 2022
Ownership
Direct
Footnotes
F1
QDEL transaction

Common Stock

Tax liability

Transaction value
$224,486
Shares
-2,170
Change %
-10%
Price
$103.45*
Shares after
18,762
Date
27 May 2022
Ownership
Direct
Footnotes
F2
QDEL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-18,762
Change %
-100%
Price
Shares after
0
Date
27 May 2022
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-4,376
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,376
Exercise price
Footnotes
F4, F5
QDEL transaction Derivative

Non-Qualified Stock Options

Disposed to Issuer

Transaction value
$0
Shares
-2,303
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,303
Exercise price
$46.41
Footnotes
F5, F6
QDEL transaction Derivative

Non-Qualified Stock Options

Disposed to Issuer

Transaction value
$0
Shares
-3,924
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,924
Exercise price
$59.12
Footnotes
F6, F7
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-3,925
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,925
Exercise price
Footnotes
F4, F8, F9
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-2,743
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,743
Exercise price
Footnotes
F4, F8, F10
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-823
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
823
Exercise price
Footnotes
F4, F8, F10
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-4,268
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,268
Exercise price
Footnotes
F4, F8, F11
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-1,962
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,962
Exercise price
Footnotes
F4, F8, F12
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-2,625
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,625
Exercise price
Footnotes
F4, F8, F13
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-3,510
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,510
Exercise price
Footnotes
F4, F8, F14
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-10,642
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,642
Exercise price
Footnotes
F4, F8, F15
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-7,256
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,256
Exercise price
Footnotes
F4, F8, F16
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Werner Kroll is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 16 footnotes

Footnote F1

Reflects release of restricted stock units that were previously reported on a Form 4.

Footnote F2

Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

Footnote F3

Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.

Footnote F4

Each restricted stock unit represents the right to receive one share of Quidel common stock.

Footnote F5

Vested in full.

Footnote F6

Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

Footnote F7

5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023.

Footnote F8

Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

Footnote F9

3,925 shares will vest on February 4, 2023.

Footnote F10

Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

Footnote F11

4,268 shares will vest on February 4, 2023.

Footnote F12

1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.

Footnote F13

1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.

Footnote F14

3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.

Footnote F15

3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.

Footnote F16

3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .